You just read:

New Data shows that Ceplene® Enhances Response to anti PD-1 and anti-PD-L1 Immune Checkpoint Inhibitors in Lymphoma and Solid Tumor Models

News provided by

Immune Pharmaceuticals Inc.

Jun 20, 2016, 17:30 ET